USPTO serial 97862513
ADD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 27, 2026
- Examiner
- MARCY, AMY ALFIERI
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ADD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
TATA CONSULTANCY SERVICES LIMITED
Mumbai, Maharashtra, IN
TATA CONSULTANCY SERVICES LIMITED
Mumbai, Maharashtra, IN
TATA CONSULTANCY SERVICES LIMITED
Mumbai, Maharashtra, IN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles T. J. Weigell
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 W. 42ND STREET, 17TH FLOORNEW YORK, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software platform used for collecting and analyzing data in the field of healthcare and optimization of healthcare, clinical and hospital processes; downloadable computer software and downloadable computer firmware used for automating control of medical equipment; downloadable computer software for information management, data collection and data analysis of medical equipment, all of the above for pharmaceutical, life sciences, medical devices and healthcare providers; downloadable computer software for clinical trials and drug development; downloadable computer software for database analysis and management; computer hardware and downloadable software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software platform for pharmacovigilance that enables automation of case processing and supports diverse data source formats; downloadable computer software to automate drug regulatory processes and compliance with drug registration; downloadable computer software for controlling and managing patient medical information | ACTIVE | — |
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, drug development and applications for drug approval; Computerized file management includes data related to drug development, regulatory compliance, and pharmacovigilance | ACTIVE | — |
| 042 | Scientific research, study and research consultation in the fields of medicine, drug delivery, clinical trials, drug development; laboratory research in the field of new drug development; Design and development of computer software for pharmacovigilance, medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software to provide aforementioned services using artificial intelligence and machine learning techniques; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Consultancy relating to quality control; Advisory services relating to all the aforesaid services; online non-downloadable computer software services for pharmacovigilance; scientific and technological services, namely, scientific and medical research in the fields of pharmaceutical, drug development, clinical trials, life sciences, and medical devices; Software as a Service (SaaS) featuring software for data collection, data management and data analytics, Platform as a Service (PaaS) featuring software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration; online non-downloadable computer software for data collection, data management and data analytics in the fields of medicine, drug delivery, clinical trials, drug development, automate drug regulatory processes and compliance with drug registration using artificial intelligence and machine learning techniques | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TATA CONSULTANCY SERVICES LIMITED
- Other trademarks owned by TATA CONSULTANCY SERVICES LIMITED
- Other trademarks owned by TATA CONSULTANCY SERVICES LIMITED
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ADD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 27, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 27, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 3, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 3, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 3, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 20, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 7, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 7, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 7, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 10, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2023 | NWAP | NEW APPLICATION ENTERED | — |